Related Experiment Video
Updated: May 3, 2026

09:01
Chronic Salmonella Infected Mouse Model
Published on: May 31, 2010
16.9K
Salmonella vaccines: lessons from the mouse model or bad teaching?
Richard A Strugnell1, Timothy A Scott1, Nancy Wang1
1Department of Microbiology and Immunology, University of Melbourne, Parkville, VIC 3010, Australia.
Current Opinion in Microbiology
|January 21, 2014
Summary
Salmonella bacteria cause significant global disease. New vaccines are needed for S. Typhimurium and S. Enteritidis, which cause invasive non-typhoidal salmonellosis (iNTS), with research informing vaccine development.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Salmonella enterica subsp. enterica serovars like Typhi, Paratyphi, Typhimurium, and Enteritidis cause substantial global disease burden.
- Diseases include enteric fever, gastroenteritis, and invasive non-typhoidal salmonellosis (iNTS).
- Existing vaccines target S. Typhi, but increased iNTS cases necessitate new vaccines for S. Typhimurium and S. Enteritidis.
Purpose of the Study:
- To review the development of vaccines against Salmonella serovars.
- To highlight the role of the murine model in understanding immune responses.
- To discuss advances in pathogenesis and their contribution to novel immunogen development.
Main Methods:
- Review of existing literature on Salmonella vaccines and murine models.
- Analysis of immune responses in murine models of typhoid fever.
- Consideration of pathogenomic and advanced animal model studies.
Main Results:
- The murine model, despite limitations, has revealed complex innate and adaptive immune responses to Salmonella infection.
- Antibody efficacy differs between human and murine models for S. Typhi and S. Typhimurium.
- S. Typhimurium lacks the Vi antigen crucial for protective immunity against typhoid fever.
Conclusions:
- Understanding complex immune responses in murine models is key for developing new Salmonella vaccines.
- Advances in understanding pathogenesis and improved animal models will aid in creating novel immunogens.
- Further research is needed to develop effective vaccines against prevalent iNTS-causing Salmonella serovars.

